Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.
作者信息
Murray Eleanor, Tomaszewski Maciej, Guzik Tomasz J
机构信息
Institute of Cardiovascular and Medical Sciences, BHF Glasgow Cardiovascular Research Centre, 126 University Place, University of Glasgow, Glasgow G12 8TA, UK.
Division of Cardiovascular Sciences, University of Manchester, Manchester, UK.
出版信息
Cardiovasc Res. 2020 Jun 1;116(7):e87-e89. doi: 10.1093/cvr/cvaa096.
Abstract
摘要
相似文献
1
Binding of SARS-CoV-2 and angiotensin-converting enzyme 2: clinical implications.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与血管紧张素转换酶2的结合：临床意义
Cardiovasc Res. 2020 Jun 1;116(7):e87-e89. doi: 10.1093/cvr/cvaa096.
2
Neuroinfection may contribute to pathophysiology and clinical manifestations of COVID-19.神经感染可能对新冠病毒疾病的病理生理学和临床表现产生影响。
Acta Physiol (Oxf). 2020 Jul;229(3):e13473. doi: 10.1111/apha.13473. Epub 2020 Apr 11.
3
[ACE2 and coronavirus - a question of balance and dynamics?].[血管紧张素转换酶2与冠状病毒——平衡与动态变化的问题？]
Lakartidningen. 2020 Apr 17;117:F3S3.
4
COVID-19: Critical Role of Angiotensin 1-7 in ACE2 Modulation.新型冠状病毒肺炎：血管紧张素1-7在血管紧张素转换酶2调节中的关键作用
Ann Acad Med Singap. 2020 Jun;49(6):398-400.
5
The interplay of hypertension, ACE-2 and SARS-CoV-2: Emerging data as the "Ariadne's thread" for the "labyrinth" of COVID-19.高血压、血管紧张素转换酶2（ACE-2）与严重急性呼吸综合征冠状病毒2（SARS-CoV-2）之间的相互作用：新出现的数据成为2019冠状病毒病（COVID-19）“迷宫”中的“阿里阿德涅之线” 。
Hellenic J Cardiol. 2020 Jan-Feb;61(1):31-33. doi: 10.1016/j.hjc.2020.05.003. Epub 2020 May 22.
6
Very low reporting rate of connective tissue diseases among coronavirus disease 2019 (Covid-19) patients and the renin-angiotensin system - An overlooked association?2019冠状病毒病（Covid-19）患者中结缔组织病的报告率极低与肾素-血管紧张素系统——一种被忽视的关联？
Eur J Intern Med. 2020 Oct;80:106-107. doi: 10.1016/j.ejim.2020.06.012. Epub 2020 Jun 12.
7
COVID-19 challenging cell biology.新冠病毒对细胞生物学构成挑战。
Protoplasma. 2020 May;257(3):619-620. doi: 10.1007/s00709-020-01506-z. Epub 2020 Apr 24.
8
Severe Acute Respiratory Syndrome Coronavirus 2 Infection and Parkinsonism: Is There Evidence for Concern?严重急性呼吸综合征冠状病毒2感染与帕金森症：是否有值得关注的证据？
Mov Disord. 2020 Oct;35(10):1725. doi: 10.1002/mds.28247.
9
The interaction between SARS-CoV-2 and ACE2 may have consequences for skeletal muscle viral susceptibility and myopathies.严重急性呼吸综合征冠状病毒2（SARS-CoV-2）与血管紧张素转换酶2（ACE2）之间的相互作用可能会对骨骼肌的病毒易感性和肌病产生影响。
J Appl Physiol (1985). 2020 Oct 1;129(4):864-867. doi: 10.1152/japplphysiol.00321.2020. Epub 2020 Jul 16.
10
Predicting the angiotensin converting enzyme 2 (ACE2) utilizing capability as the receptor of SARS-CoV-2.预测血管紧张素转化酶 2（ACE2）作为 SARS-CoV-2 受体的利用能力。
Microbes Infect. 2020 May-Jun;22(4-5):221-225. doi: 10.1016/j.micinf.2020.03.003. Epub 2020 Mar 19.
引用本文的文献
1
The Relation of Angiotensin-Converting Enzyme 2, Renin-Angiotensin-Aldosterone System Inhibitors, and Arterial Stiffness in Acute COVID-19 Emergency Department Patients-A Prospective Observational Study.急性新冠肺炎急诊科患者中血管紧张素转换酶2、肾素-血管紧张素-醛固酮系统抑制剂与动脉僵硬度的关系——一项前瞻性观察研究
J Clin Med. 2025 Mar 25;14(7):2233. doi: 10.3390/jcm14072233.
2
New Onset of Acute and Chronic Hepatic Diseases Post-COVID-19 Infection: A Systematic Review.新型冠状病毒肺炎感染后急性和慢性肝病的新发：一项系统评价
Biomedicines. 2024 Sep 10;12(9):2065. doi: 10.3390/biomedicines12092065.
3
High-dose vitamin D supplementation in patients with COVID-19: A meta-analysis of randomized controlled trials.新冠病毒肺炎患者大剂量补充维生素D：一项随机对照试验的荟萃分析
Food Sci Nutr. 2023 Dec 7;12(3):1808-1817. doi: 10.1002/fsn3.3875. eCollection 2024 Mar.
4
A Review of Pathology and Analysis of Approaches to Easing Kidney Disease Impact: Host-Pathogen Communication and Biomedical Visualization Perspective : Advanced Microscopy and Visualization of Host-Pathogen Communication.缓解肾脏疾病影响的病理学综述及方法分析：宿主-病原体相互作用与生物医学可视化视角：宿主-病原体相互作用的高级显微镜检查与可视化
Adv Exp Med Biol. 2023;1406:41-57. doi: 10.1007/978-3-031-26462-7_3.
5
Artificial Intelligence-Assisted Chest X-ray for the Diagnosis of COVID-19: A Systematic Review and Meta-Analysis.人工智能辅助胸部X光用于诊断新型冠状病毒肺炎：一项系统评价与荟萃分析
Diagnostics (Basel). 2023 Feb 5;13(4):584. doi: 10.3390/diagnostics13040584.
6
Endothelial Dysfunction in COVID-19: Potential Mechanisms and Possible Therapeutic Options.新冠病毒病中的内皮功能障碍：潜在机制与可能的治疗选择
Life (Basel). 2022 Oct 14;12(10):1605. doi: 10.3390/life12101605.
7
Role of the renin-angiotensin system in the development of COVID-19-associated neurological manifestations.肾素-血管紧张素系统在新型冠状病毒肺炎相关神经表现发展中的作用。
Front Cell Neurosci. 2022 Sep 16;16:977039. doi: 10.3389/fncel.2022.977039. eCollection 2022.
8
Deep immunophenotyping reveals biomarkers of multisystemic inflammatory syndrome in children in a Latin American cohort.深度免疫表型分析揭示了拉丁美洲队列中儿童多系统炎症综合征的生物标志物。
J Allergy Clin Immunol. 2022 Nov;150(5):1074-1085.e11. doi: 10.1016/j.jaci.2022.09.006. Epub 2022 Sep 15.
9
SARS-CoV-2: An Overview of the Genetic Profile and Vaccine Effectiveness of the Five Variants of Concern.严重急性呼吸综合征冠状病毒2：五种值得关注的变异株的基因概况及疫苗有效性概述
Pathogens. 2022 Apr 26;11(5):516. doi: 10.3390/pathogens11050516.
10
COVID-19's Clinical-Pathological Evidence in Relation to Its Repercussion on the Central and Peripheral Nervous System.新型冠状病毒肺炎（COVID-19）对中枢及外周神经系统影响的临床病理证据。
Adv Exp Med Biol. 2021;1353:197-215. doi: 10.1007/978-3-030-85113-2_11.
本文引用的文献
1
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study.中国武汉成人 COVID-19 住院患者的临床病程和死亡危险因素：一项回顾性队列研究。
Lancet. 2020 Mar 28;395(10229):1054-1062. doi: 10.1016/S0140-6736(20)30566-3. Epub 2020 Mar 11.
2
Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China.中国武汉 2019 年冠状病毒病肺炎患者急性呼吸窘迫综合征和死亡的相关危险因素。
JAMA Intern Med. 2020 Jul 1;180(7):934-943. doi: 10.1001/jamainternmed.2020.0994.
3
Clinical Characteristics of Coronavirus Disease 2019 in China.《中国 2019 年冠状病毒病临床特征》
N Engl J Med. 2020 Apr 30;382(18):1708-1720. doi: 10.1056/NEJMoa2002032. Epub 2020 Feb 28.
4
Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China.《武汉 2019 年新型冠状病毒感染的肺炎 138 例住院患者临床特征分析》
JAMA. 2020 Mar 17;323(11):1061-1069. doi: 10.1001/jama.2020.1585.
5
Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia.血管紧张素转换酶抑制剂和他汀类药物对病毒性肺炎的影响。
Proc (Bayl Univ Med Cent). 2018 Oct 26;31(4):419-423. doi: 10.1080/08998280.2018.1499293. eCollection 2018 Oct.
6
Elevated plasma angiotensin converting enzyme 2 activity is an independent predictor of major adverse cardiac events in patients with obstructive coronary artery disease.血浆血管紧张素转换酶 2 活性升高是阻塞性冠状动脉疾病患者主要不良心脏事件的独立预测因子。
PLoS One. 2018 Jun 13;13(6):e0198144. doi: 10.1371/journal.pone.0198144. eCollection 2018.
7
Altered Lipid Metabolism in Recovered SARS Patients Twelve Years after Infection.恢复期 SARS 患者感染 12 年后的脂质代谢改变。
Sci Rep. 2017 Aug 22;7(1):9110. doi: 10.1038/s41598-017-09536-z.
8
Angiotensin converting enzyme 2 activity and human atrial fibrillation: increased plasma angiotensin converting enzyme 2 activity is associated with atrial fibrillation and more advanced left atrial structural remodelling.血管紧张素转换酶 2 活性与人类心房颤动：血浆血管紧张素转换酶 2 活性增加与心房颤动和更严重的左心房结构重构相关。
Europace. 2017 Aug 1;19(8):1280-1287. doi: 10.1093/europace/euw246.
9
Angiotensin-converting enzyme 2 (ACE2) mediates influenza H7N9 virus-induced acute lung injury.血管紧张素转换酶2（ACE2）介导H7N9流感病毒引起的急性肺损伤。
Sci Rep. 2014 Nov 13;4:7027. doi: 10.1038/srep07027.
10
Angiotensin II mediates angiotensin converting enzyme type 2 internalization and degradation through an angiotensin II type I receptor-dependent mechanism.血管紧张素II通过血管紧张素II 1型受体依赖性机制介导血管紧张素转换酶2的内化和降解。
Hypertension. 2014 Dec;64(6):1368-1375. doi: 10.1161/HYPERTENSIONAHA.114.03743. Epub 2014 Sep 15.
Zotero 插件